跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AYBINTIO 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
AYBINTIO 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
AYBINTIO 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Samsung Bioepis Nl B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 7, 2020
Approval ID
64f5e2995c8a55df
Company
Samsung Bioepis Nl B.V.
Type
Standard
Approval Details
Approval Id
64f5e2995c8a55df
Drug Cima Aemps Name
AYBINTIO 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number
1201454001
Holder Company Name
Samsung Bioepis Nl B.V.
Marketing Company Name
Organon Salud S.L.
Holder Company Detail Path
/organization/samsung-bioepis-nl-b-v
Authorization Date
2020-09-07
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
25 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Samsung Bioepis Nl B.V.
Company Detail Path
/organization/samsung-bioepis-nl-b-v
Company Information
Pharmaceutical Company Name
Samsung Bioepis NL B.V.
Country Name
Netherlands
Active Ingredients
BEVACIZUMAB
25 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 7, 2020
Approval ID
64f5e2995c8a55df
Type
Standard
Back to CIMA-AEMPS Approvals